Your browser doesn't support javascript.
loading
Status of TMPRSS2-ERG fusion in prostate cancer patients from India: correlation with clinico-pathological details and TMPRSS2 Met160Val polymorphism.
Bhanushali, Aparna; Rao, Pranesh; Raman, Vaishnavi; Kokate, Prajakta; Ambekar, Asawari; Mandva, Swarna; Bhatia, Simi; Das, B R.
Affiliation
  • Bhanushali A; Research and Development, SRL Ltd, Mumbai 400 062, India.
  • Rao P; Research and Development, SRL Ltd, Mumbai 400 062, India.
  • Raman V; Research and Development, SRL Ltd, Mumbai 400 062, India.
  • Kokate P; Department of Cytogenetics, SRL Ltd, India.
  • Ambekar A; Department of Histopathology, Apollo Hospital, Vashi, India.
  • Mandva S; Department of Cytogenetics, SRL Ltd, India.
  • Bhatia S; Department of Histopathology, SRL Ltd, India.
  • Das BR; Research and Development, SRL Ltd, Mumbai 400 062, India.
Prostate Int ; 6(4): 145-150, 2018 Dec.
Article in En | MEDLINE | ID: mdl-30505817
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Prognostic_studies Language: En Journal: Prostate Int Year: 2018 Document type: Article Affiliation country:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Prognostic_studies Language: En Journal: Prostate Int Year: 2018 Document type: Article Affiliation country: